IRD 8-K 2026-08-06

Opus Genetics, Inc. (IRD) 8-K dated 2026-08-06 — accession 0001628280-26-053824. This URL is the filing, not the IRD hub.

Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.

Opus Genetics, Inc. filed a 8-K on 2026-08-06. Accession 0001628280-26-053824.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported IRD revenue for 2026-06-30 was $2.9M. Net income was -$73.6M. Revenue was up 35.0% from 2026-03-31 to 2026-06-30. IRD currently screens at market cap $35.7M.

Not investment advice. The IRD SEC hub lists recent forms. The stock page is the research view.